TENX Live signaler | Maksimer profitt med Getagraph.com

KJøP 124928 min ago

@ $4.72

Utstedt: 13 feb 2024 @ 15:30

Avkastning: -24.38%

Forrige signal: feb 12 - 16:27

Forrige signal: Selg

Avkastning: -6.14 %

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 22:00):

Stats
Dagens volum	12 100.00
Gjennomsnittsvolum	115 901
Markedsverdi	6.99M
EPS	$0 ( 2024-04-01 )
Neste inntjeningsdato	( $-2.40 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.0280 (0.78%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-11	Hoffman Lawrence R	Sell	0	Common Stock
2022-09-21	Rich Stuart	Buy	1 909 585	Common Stock
2022-09-21	Rich Stuart	Sell	1 909 585	Common Stock
2022-08-11	Doogan Declan	Sell	567 871	Common Stock
2022-06-09	Rich Stuart	Buy	100 000	Stock Option (right to buy)

INSIDER POWER
18.62
Last 92 transactions
Buy: 35 341 052 \| Sell: 26 670 670

Tenax Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
VRM	0.947
LGVN	0.94
EBIX	0.939
VRAY	0.938
RIDE	0.938
TVACW	0.936
AGRI	0.935
SRNGW	0.933
KSPN	0.932
REVB	0.927

10 Mest negative korrelasjoner
TIOA	-0.943
MSDA	-0.939
NVCN	-0.938
BRIVU	-0.937
SILK	-0.934
SGII	-0.932
BRIV	-0.929
PRAX	-0.927
ALOR	-0.921
STAY	-0.919

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Tenax Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-7 570.00 (0.00 %)
EPS:	$-31.04

FY	2023
Omsetning:	$0
Bruttogevinst:	$-7 570.00 (0.00 %)
EPS:	$-31.04

FY	2022
Omsetning:	$0
Bruttogevinst:	$-113 332 (0.00 %)
EPS:	$-600.46

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.580

Financial Reports:

No articles found.

Tenax Therapeutics Inc

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.